Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.071 CHF
-3.79%
Market Closed
Updated:
May 15, 2024
Addex Therapeutics Ltd
Interest Income Expense
|
Addex Therapeutics Ltd
Interest Income Expense Peer Comparison
Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
Interest Income Expense
-CHf274.9k
|
CAGR 3-Years
24%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Interest Income Expense
-$35.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Interest Income Expense
-CHf599k
|
CAGR 3-Years
5%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Interest Income Expense
-CHf9.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Interest Income Expense
-CHf21.9m
|
CAGR 3-Years
-278%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Interest Income Expense?
Interest Income Expense
-274.9k
CHF
-274.9k
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Interest Income Expense amounts to -274.9k CHF.
What is Addex Therapeutics Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-5%
-5%
Over the last year, the Interest Income Expense growth was 3%. The average annual Interest Income Expense growth rates for Addex Therapeutics Ltd have been 24% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
